DuPont today announced that Karin De Bondt and Anne Noonan will become members of the future board of directors (the "Electronics Board") for the independent Electronics public company that will be ...

was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...

Dr. Laken also held strategic drug development leadership roles at Rhythm Pharmaceuticals, Pfizer and Wyeth ... Forward-looking statements include, but are not limited to, statements concerning ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Morgan Stanley analyst Terence Flynn notes that Pfizer (PFE) announced that after a review of the totality of the data for its pipeline oral ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

The stock's fall snapped a three-day winning streak.

It was spun off from the British drugmaker in 2022. Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock (BLK.N), opens new tab, will become Haleon's largest ...

Pfizer shares moved lower in premarket trading Monday after the drugmaker said it is scrapping its experimental weight-loss pill danuglipron, keeping the company on the sidelines of the booming ...

Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, will become Haleon's largest shareholder with over a 5% stake, according to data compiled by LSEG.

This result demonstrates the strength of Pfizer's core business. With limited patent losses and fewer older drugs following the divestiture of its off-patent division Upjohn (now part of Viatris ...

Pfizer shares fell 1.32% after reports U.S. prosecutors are investigating claims from GSK about the timing of Pfizer’s COVID-19 vaccine. Pfizer denies allegations of delaying vaccine results for ...